Clinical trial
Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5…
NCT00357292 · Laboratoires Thea, Industry · Completed
Key facts
| NCT number | NCT00357292 |
|---|---|
| Title | Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers |
| Official title | Comparison of the Ocular Tolerance, the Safety and the Ocular Pharmacokinetics After One Drop of Three Different Concentrations of T1225 (0.5% - 1.0% - 1.5%) in 48 Healthy Volunteers |
| Lead sponsor | Laboratoires Thea, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Eye Infections, Bacterial |
| Intervention type | Drug |
| Interventions | Azithromycin (T1225) |
| Start date | Mar 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Jul 27, 2006 |
| Last update posted | Jul 27, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: